CL
UTHR icon

CSS LLC’s United Therapeutics UTHR Stock Holding History

CSS LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$471K – 1174
2022
Q2 		$471K Buy
+2,000
New +$407K 0.02% 590
2015
Q2 		– Sell
-8,000
Closed -$1.38M – 793
2015
Q1 		$1.38M Buy
+8,000
New +$1.22M 0.07% 232

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CSS LLC's UTHR Position: Q2 2026 in Review

CSS LLC reduced its United Therapeutics (UTHR) stake by 31% in Q2 2026, selling an estimated $487K and leaving 1,892 shares worth $1.03M. The position accounts for 0.04% of the portfolio, ranked #341.

CSS LLC first reported a position in UTHR in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.63M in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • CSS LLC held 1,892 shares of United Therapeutics worth $1.03M as of Q2 2026.
  • CSS LLC sold 865 United Therapeutics shares in Q2 2026, an estimated $487K.
  • United Therapeutics made up 0.04% of CSS LLC's portfolio in Q2 2026, its #341 holding.
  • CSS LLC first reported a position in United Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • CSS LLC's United Therapeutics position peaked at $1.63M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on CSS LLC's 13F filing for Q2 2026, filed 14 Aug 2026.